Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05041231
Other study ID # 133
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 25, 2021
Est. completion date January 20, 2023

Study information

Verified date January 2023
Source Vita Care
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Osteoarthrosis (OA), a multifactorial degenerative process, is responsible for joint pain and functional limitation. In the hand, more specifically in the proximal and distal interphalangeal joints of the fingers, it is one of the sites of greatest manifestation of the disease. Numerous treatments, whether drug, rehabilitation or surgery, have been proposed with the aim of both interrupting the natural evolution of the disease and alleviating or stopping the symptoms. This study aims to evaluate the effectiveness of personalized Photobiomodulation Therapy (PBT) with regard to alleviating symptoms and improving the quality of life of these patients with the disease.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date January 20, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 40 Years to 100 Years
Eligibility Inclusion Criteria: - Clinical and radiological diagnosis of OA of the fingers of the hand and Rizarthrosis - Patients with pain for at least 3 months - Patients undergoing treatment and rehabilitation for finger OA and rhizarthrosis - Patient with good understanding of the Portuguese language who agrees to participate and sign the ICF Exclusion Criteria: - Posttraumatic arthritic changes - Systemic inflammatory arthritis (Rheumatoid Arthritis, Lupus Erythematosus, Psoriasis…) - Patients with local or systemic, acute or chronic infections

Study Design


Intervention

Device:
Photobiomodulation therapy (PBT)
Any invasive procedures will be done. The treatment in question will be done by a device that looks like a bracelet, which is placed on the hand/fingers to emit light/laser and does not cause pain or temperature change. There will be 8 photobiomodulation sessions, 2 per week, 10 minutes each session. The dosimetric parameters of the therapy will be carried out in a standardized and personalized way, with programming of the light and all the necessary information so that the device can carry out the application of the treatment application of electromagnetic waves in the red and infrared spectral range 660-1000 nm).
Sham Photobiomodulation therapy (Sham PBT)
Similar to active PBT, however, the device will not provide the active electromagnetic waves)

Locations

Country Name City State
Brazil Instituto Vita São Paulo SP

Sponsors (2)

Lead Sponsor Collaborator
Vita Care Tegos S.A.

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Pain at Visual analogue scale for pain 4 weeks and 2 months
Primary Change from Baseline Arm, Shoulder and Hand Disability The Disabilities of the Arm, Shoulder and Hand Score 4 weeks and 2 months
Secondary Change from Baseline Hand grip Hand grip strenght measured by Digital Hand Dynamometer 4 weeks and 2 months
Secondary Change from Baseline Pinch force Pulp to pulp (pinch) force 4 weeks and 2 months
Secondary Willingness to recommend the treatment Net Promoter Score 4 weeks and 2 months
Secondary Change from Baseline Hand Disability Brief Michigan questionnaire 4 weeks and 2 months
See also
  Status Clinical Trial Phase
Completed NCT04657926 - A Trial of APPA in the Treatment of Knee Osteoarthritis Phase 2
Completed NCT02536833 - A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects Phase 2
Completed NCT03014037 - Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration N/A
Recruiting NCT05937542 - A Qualitative Investigation of CLEAT Participants
Completed NCT03644615 - A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT03850665 - Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach N/A
Completed NCT02826902 - Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial N/A
Completed NCT04402502 - Dynamic 4DCT to Examine Wrist Carpal Mechanics N/A
Completed NCT02923700 - Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial Phase 4
Completed NCT04564053 - Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants Phase 1
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT05036174 - Diphenhydramine Ointment for Knee Osteoarthritis N/A
Recruiting NCT02912429 - Onlay vs. Inlay Patellofemoral Arthroplasty N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A
Active, not recruiting NCT02723929 - Effects of tDCS and tUS on Pain Perception in OA of the Knee
Withdrawn NCT02921594 - Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties N/A
Terminated NCT02820766 - Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting N/A